COST-EFFECTIVENESS ANALYSIS OF PREGABALIN FOR THE TREATMENT OF NEUROPATHIC PAIN IN COLOMBIA

被引：0
|
作者：
Ordonez Molina, J. E. [1 ]
Orozco Giraldo, J. J. [1 ]
Gutierrez-Ardila, M., V [2 ]
机构：
[1] CES Univ, Medellin, Colombia
[2] Pfizer SAS, Bogota, Colombia
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A118 / A118
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF PREGABALIN IN THE TREATMENT OF CENTRAL NEUROPATHIC PAIN
    Karbusicka, M.
    Kolek, M.
    Duba, J.
    Vothova, P.
    Kova, Dolec J.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A670 - A670
  • [2] Pregabalin vs gabapentin in the treatment of neuropathic pain in Italy: A cost-effectiveness analysis
    Pradelli, L.
    Marchettini, P.
    Iannazzo, S.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A375 - A375
  • [3] A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan
    Akazawa, Manabu
    Igarashi, Ataru
    Ebata, Nozomi
    Murata, Tatsunori
    Zeniya, Shigeki
    Haga, Yuri
    Nozawa, Kazutaka
    Fujii, Koichi
    Taguchi, Toshihiko
    [J]. JOURNAL OF PAIN RESEARCH, 2019, 12 : 2785 - 2796
  • [4] The cost-effectiveness of lyrica (pregabalin) in patients with central neuropathic pain
    Ramos, E.
    Tran, T.
    Landry, P. A.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A158 - A158
  • [5] Cost-effectiveness analysis of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy in Mexico
    Arreola-Ornelas, H.
    Dorantes-Aguilar, J.
    Garcia-Mollinedo, M. D. L.
    Rosado-Buzzo, A. A.
    Mould-Quevedo, J.
    Davila-Loaiza, G.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A17 - A18
  • [6] Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland
    Mankowski, Colette
    Patel, Sachin
    Trueman, David
    Bentley, Anthony
    Poole, Chris
    [J]. PLOS ONE, 2016, 11 (03):
  • [7] Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan
    Igarashi, Ataru
    Akazawa, Manabu
    Murata, Tatsunori
    Taguchi, Toshihiko
    Sadosky, Alesia
    Ebata, Nozomi
    Willke, Richard
    Fujii, Koichi
    Doherty, Jim
    Kobayashi, Makoto
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 505 - 520
  • [8] BUDGET IMPACT OF PREGABALIN FOR THE TREATMENT OF NEUROPATHIC PAIN IN COLOMBIA
    Ordonez Molina, J. E.
    Orozco Giraldo, J. J.
    Gutierrez-Ardila, M., V
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A114 - A114
  • [9] A Cost-Effectiveness Analysis of the Effect of Pregabalin Versus Usual Care in the Treatment of Refractory Neuropathic Pain in Routine Medical Practice in Spain
    de Salas-Cansado, Marina
    Perez, Concepcion
    Saldana, Maria T.
    Navarro, Ana
    Rejas, Javier
    [J]. PAIN MEDICINE, 2012, 13 (05) : 699 - 710
  • [10] Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review
    Ruiz-Negron, Natalia
    Menon, Jyothi
    King, Jordan B.
    Ma, Junjie
    Bellows, Brandon K.
    [J]. PHARMACOECONOMICS, 2019, 37 (05) : 669 - 688
12345